China Sky One Medical's Myocardial Infarction and Urine Microalbumin Diagnostic Kits receive CE certification

China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced the receipt of Conformite Europeenne (CE) certification for its Myocardial Infarction and Urine Microalbumin Diagnostic Kits. The CE marking certifies that the two products have met the European Union (EU) health and safety standards and are approved for sale in the 27 EU countries and four members of the European Free Trade Association (EFTA).

The Company also received ISO 9001 and ISO 13485 certifications for its Myocardial Infarction, Urine Microalbumin and Early Pregnancy Diagnostic Kits. ISO certifications set stringent, globally recognized management system standard that enhances its product marketing. The two ISO certifications are valid through October 2014.

Investors can visit the Company's website http://www.cski.com.cn , under the section of News, to view all these certifications.

"We are honored to receive the CE marking and the ISO certifications, which reinforce the high quality of our products and manufacturing standards and pave way for exporting the diagnostic kits in the EU and other markets," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "According to agreements with our distributors in Indonesia, Turkey, Singapore and Vietnam, we will enter into definitive contracts with the distributors following receipt of the CE marking. The CE marking and ISO certifications also strengthen the Company's ability to advance our negotiations with potential distributors from many other countries. We look forward to launching our diagnostic kits in promising international markets beginning in 2010."

SOURCE China Sky One Medical, Inc.